You are using an older browser version. Please use a supported version for the best MSN experience.

New COVID-19 test funded by NBA, NBPA gets FDA approval

Yardbarker logo Yardbarker 8/15/2020 Erin Walsh, Yardbarker
Adam Silver wearing a suit and tie: The NBA and NBPA funded the development of a new COVID-19 that should be faster and cheaper for consumers. © Quinn Harris-USA TODAY Sports The NBA and NBPA funded the development of a new COVID-19 that should be faster and cheaper for consumers.

The NBA and NBPA funded the development of a saliva-based COVID-19 test by Yale University, and now there's been a breakthrough in its development. 

According to ESPN's Zach Lowe, the U.S. Food and Drug Administration issued emergency authorization for public use of the test known as SalivaDirect. 

SalivaDirect is designed for widespread public coronavirus screening and Lowe explains that it'll likely cost consumers between $15-$20. 

Yale, while working with the NBA, used the saliva test together with nasal swab testing, and the results "almost universally matched."

Saliva samples must be sent to the lab for testing, but the future of saliva testing is bright. Lowe continues to say that, ideally, consumers will be able to use a self-saliva test to receive results in minutes instead of hours or days. 

Self-screening will help cut down the spread of the coronavirus.

Subscribe to Yardbarker's Morning Bark, the most comprehensive newsletter in sports. Customize your email to get the latest news on your favorite sports, teams and schools. Emailed daily. Always free! Sign up now ▸

More must-reads:

Related slideshow: The tallest players in NBA history (Provided by Yardbarker)

AdChoices
AdChoices

More From Yardbarker

image beaconimage beaconimage beacon